A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This study will have one stage consisting of multiple treatment visits. The study is designed
to assess the safety and bioavailability of Entera's oral PTH(1 - 34) in adult male healthy
volunteers in various formulation. The study is also designed to assess the reproducibility
of pharmacokinetic profiles with various formulations.